Targeting MDSCs enhance therapeutic vaccination responses against lung cancer

por Srivastava, Minu K., Dubinett, Steven, Sharma, Sherven
Publicado 2012

APX005M, a CD40 agonist antibody with unique epitope specificity and Fc receptor binding profile for optimal therapeutic application

por Filbert, Erin L., Björck, Pia K., Srivastava, Minu K., Bahjat, Frances R., Yang, Xiaodong
Publicado 2021

Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth

por Kar, Upendra K., Srivastava, Minu K., Andersson, Åsa, Baratelli, Felicita, Huang, Min, Kickhoefer, Valerie A., Dubinett, Steven M., Rome, Leonard H., Sharma, Sherven
Publicado 2011

Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer

por Srivastava, Minu K., Zhu, Li, Harris-White, Marni, Kar, Upendra, Huang, Min, Johnson, Ming F., Lee, Jay M., Elashoff, David, Strieter, Robert, Dubinett, Steven, Sharma, Sherven
Publicado 2012

Correction: Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer

por Srivastava, Minu K., Zhu, Li, Harris-White, Marni, Kar, Upendra K, Huang, Min, Johnson, Ming F., Lee, Jay M., Elashoff, David, Strieter, Robert, Dubinett, Steven, Sharma, Sherven
Publicado 2012

Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer

por Srivastava, Minu K, Zhu, Li, Harris-White, Marni, Huang, Min, St John, Maie, Lee, Jay M, Salgia, Ravi, Cameron, Robert B, Strieter, Robert, Dubinett, Steven, Sharma, Sherven
Publicado 2012

Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL

por Tan, Yi-Hung Carol, Mirzapoiazova, Tamara, Won, Brian M., Zhu, Li, Srivastava, Minu K., Vokes, Everett E., Husain, Aliya N., Batra, Surinder K., Sharma, Sherven, Salgia, Ravi
Publicado 2017

Early intervention with a small molecule inhibitor for tumor nefosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer’s disease

por Gabbita, S Prasad, Srivastava, Minu K, Eslami, Pirooz, Johnson, Ming F, Kobritz, Naomi K, Tweedie, David, Greig, Nigel H, Zemlan, Frank P, Sharma, Sherven P, Harris-White, Marni E
Publicado 2012

IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer

por Kachroo, Puja, Lee, Mi-Heon, Zhang, Ling, Baratelli, Felicita, Lee, Gina, Srivastava, Minu K, Wang, Gerald, Walser, Tonya C, Krysan, Kostyantyn, Sharma, Sherven, Dubinett, Steven M, Lee, Jay M
Publicado 2013

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer

por Pellini, Bruna, Madison, Russell W., Childress, Merrida A., Miller, Shoshana T., Gjoerup, Ole, Cheng, Jason, Huang, Richard S.P., Krainock, Michael, Gupta, Pratyush, Zou, Wei, Shames, David S., Moshkevich, Solomon, Ballinger, Marcus, Liu, Minetta C., Young, Amanda, Srivastava, Minu K., Oxnard, Geoffrey R., Socinski, Mark A.
Publicado 2023

Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III I...

por Zhou, Caicun, Srivastava, Minu K, Xu, Hao, Felip, Enriqueta, Wakelee, Heather, Altorki, Nasser, Reck, Martin, Liersch, Rüdiger, Kryzhanivska, Anna, Oizumi, Satoshi, Tanaka, Hiroshi, Hamm, John, McCune, Steven L, Bennett, Elizabeth, Gitlitz, Barbara, McNally, Virginia, Ballinger, Marcus, McCleland, Mark, Zou, Wei, Das Thakur, Meghna, Novello, Silvia
Publicado 2023